Ruchin Kansal

Ruchin Kansal is the Digital Business Strategy leader for Healthcare, Insurance and Life Sciences (HIL) at Virtusa. He brings strategy consulting experience from his two prior stints at Deloitte and Gemini Consulting/Capgemini. He is the author of “Redefining Innovation: Embracing The 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry” focused on helping incumbents drive innovation and new growth opportunities. (Publisher: Taylor & Francis/Routledge). In 2016, Medical Marketing & Media recognized Ruchin with its annual Top 40 Healthcare Transformers Award. He has been invited to the White House Office of Science and Technology Partnerships to share ideas on healthcare research. He serves on the Board of Directors for Stanford Medicine X and Weston Education Foundation. Ruchin received his MBA from NYU-Stern, bachelor’s from IIT, Roorkee (India) and leadership training at Duke University and Kunshan University (China). In his free time, Ruchin enjoys spending time with his wife Gunjan (a physician), son Neil (freshman in high school and a budding cellist) and their dog Roo. They like to travel together, having visited all 50 states in the US, and more than 30 countries and counting.


Posts by Ruchin Kansal

Only two future events are certain – death, and disruption of the status quo

Introducing “Redefining Innovation: Embracing The 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry” There is a crisis of innovation for incumbents in the biopharmaceutical industry that should concern all of us. Once innovators who were responsible for some of the most significant advances in medical care the human race has seen, these organizations have 

Continue Reading…